Serial Number | 88615918 |
Word Mark | DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS |
Filing Date | Friday, September 13, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 13, 2021 |
Registration Number | 6414007 |
Registration Date | Tuesday, July 13, 2021 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, November 3, 2020 |
Indication of Colors claimed | The color(s) blue, light blue, and black is/are claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS" |
Description of Mark | The mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP" contained within a blue oblong shaped pill design. All instances of the color white in the mark represent background and/or transparent areas only and are not features of the mark. |
Goods and Services | Anti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide |
Goods and Services | Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection |
Pseudo Mark | DESCOVY EMTRICITABINE TWO HUNDRED MILLIGRAMS / TENOFOVIR ALAFENAMIDE TWENTY FIVE MILLIGRAMS TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 23, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 23, 2019 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Gilead Sciences Ireland UC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Carrigtohill, Co. Cork IE |
Party Name | Gilead Sciences Ireland UC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Carrigtohill, Co. Cork IE |
Party Name | Gilead Sciences Ireland UC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Carrigtohill, Co. Cork IE |
Event Date | Event Description |
Tuesday, July 13, 2021 | REGISTERED-PRINCIPAL REGISTER |
Friday, June 4, 2021 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Monday, May 3, 2021 | NOTICE OF ALLOWANCE CANCELLED |
Friday, June 4, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Monday, May 3, 2021 | TEAS DELETE 1(B) BASIS RECEIVED |
Tuesday, December 29, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 29, 2020 | ELECTRONIC RECORD REVIEW COMPLETE |
Friday, September 25, 2020 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Tuesday, September 22, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 22, 2020 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, September 22, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 22, 2020 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 22, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, September 1, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, September 1, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 26, 2020 | ASSIGNED TO LIE |
Thursday, August 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 6, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, April 6, 2020 | NON-FINAL ACTION E-MAILED |
Monday, April 6, 2020 | NON-FINAL ACTION WRITTEN |
Friday, March 13, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, March 12, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 12, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, December 21, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, December 21, 2019 | NON-FINAL ACTION E-MAILED |
Saturday, December 21, 2019 | NON-FINAL ACTION WRITTEN |
Saturday, December 14, 2019 | ASSIGNED TO EXAMINER |
Tuesday, September 24, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, September 23, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, September 17, 2019 | NEW APPLICATION ENTERED IN TRAM |